Inova Translational Medicine Institute

NIH and Inova Health System are populating the nascent Genomic Ascertainment Cohort with data from ClinSeq and Inova's longitudinal family study

During a two-year pilot, the Genomic Ascertainment Cohort will collect 10,000 genotypes and make patients available for follow-up exams to confirm predictions.

Inova Translational Medicine Institute has become more efficient running Cloudera's platform, but continues to evaluate this new world of bioinformatics.

Inova Health System is on track to open applications for its Personalized Health Accelerator in July, likely the first such accelerator in the US hosted by a healthcare provider.

Inova plans to offer broad and condition-specific PGx gene panels in its specialty clinics and is negotiating with payors for reimbursement. 

Inova is using Translational's platform to evaluate data from MediMap, a new test that evaluates pharmacogenetics markers in seven genes in newborns.

At Inova Women's Hospital, all new parents have the chance to have pharmacogenetic testing for their babies with the results stored in the electronic medical record.  

Thirteen institutions and life sciences companies have teamed up to launch the free repository that will offer access to allele frequency information from genomes and exomes.

Inova will use GenoSpace's solution to analyze clinical and genomic data from an ongoing whole-genome sequencing initiative.

The Inova Translational Medicine Institute has been exploring the diagnostic use of whole-genome sequencing in newborns with unexplained syndromes in a research setting and plans to transition to a clinical diagnostic test by the end of this year.

Pages

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.